The latest market price of bimetinib/bemetinib in 2025

Binimetinib is a targeted therapy drug that is a MEK inhibitor and is mainly used to treat malignant tumors related to BRAF mutations, such as advanced or metastatic melanoma. Its mechanism of action is to inhibit the activity of MEK1 and MEK2 kinases, thereby inhibiting the MAPK signaling pathway in tumor cells, limiting the proliferation and spread of tumor cells, and thereby reducing tumor growth.

In the market, especially in Europe and the United States, bimetinib has been sold for many years and has become one of the important drugs for the treatment of advanced or metastatic melanoma. However, for the treatment of bimetinib, the original drug has not yet been launched in the domestic market, so there is no formal medical insurance reimbursement in China. Due to the particularity of imported drugs, domestic patients can usually only obtain bimetinib through overseas purchase of drugs, and the price of drugs fluctuates due to exchange rates and regional differences.

Bimetinib is already sold in overseas markets, especially in Europe and the United States. Common specifications are15mg×84 tablets and 15mg×168 tablets, and the price may be close to 20,000 yuan (price is affected by exchange rate fluctuations). This price is relatively expensive, especially for patients who require long-term treatment.

With the development of the global generic drug market, generic drugs of bimetinib have appeared on the market. The prices of these generic drugs are relatively low. For example, the 15 mg × 180 tablets of generic drugs produced by Lucius Pharmaceutical Factory in Laos are sold for about more than 6,000 yuan. The quality of generic drugs is basically the same as the original drugs, providing patients with a more economical treatment option.

Although generic drugs are less expensive, patients should make sure they come from reliable sources when choosing drugs, especially when purchasing drugs overseas, to avoid quality issues. Bimetinib is a prescription drug. Patients should use it under the guidance of a doctor and check the treatment effect regularly to ensure the safety and effectiveness of the treatment.

Reference materials:https://go.drugbank.com/drugs/DB11967